OR101 Outcomes of patients with aspirin-exacerbated respiratory disease on omalizumab

The current treatment for patients with aspirin-exacerbated respiratory disease (AERD) who have uncontrolled asthma or chronic rhinosinusitis is aspirin desensitization. However, some patients are unable to undergo or fail desensitization, and treatment with omalizumab is an option although efficacy data is scarce.

http://ift.tt/2zbpMez